Discovery of vaccine-like recombinant SARS-CoV-2 circulating in human
Abstract For viral diseases, vaccination with live attenuated vaccine (LAV) is one of the most effective means for fighting the diseases. However, LAV occasionally overflows from vaccinated individuals circulate in the population with unforeseen consequences. Currently, SARS-CoV-2 LAVs are undergoin...
Main Authors: | Daniel Chang He, Cheng-Qiang He |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | Virology Journal |
Online Access: | https://doi.org/10.1186/s12985-022-01945-5 |
Similar Items
-
Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
by: Qiao Wang, et al.
Published: (2023-03-01) -
Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
by: Yi-Sheng Sun, et al.
Published: (2021-09-01) -
Construction and Immunogenicity of a Recombinant Pseudorabies Virus Expressing SARS-CoV-2-S and SARS-CoV-2-N
by: Ruoying Li, et al.
Published: (2022-08-01) -
SARS-CoV-2 recombinant XN, Italy
by: Federica Novazzi, et al.
Published: (2022-08-01) -
Effects of Different Types of Recombinant SARS-CoV-2 Spike Protein on Circulating Monocytes’ Structure
by: Marco Vettori, et al.
Published: (2023-05-01)